Tag: CYCC stock

Analysts Viewpoint

Potential Price Increase for Cyclacel Pharmaceuticals Inc (CYCC) After Recent Insider Activity

In a filing, Cyclacel Pharmaceuticals Inc revealed its Interim CEO Lazar David E. unloaded Company’s shares for reported $5.51 million

Knoxdaily.com is a Financial news website that offers insight about stock markets and equities. This platform aims to provide public and private capital sharing recommendations that are practical and comprehensive, both in terms of updates and analysis.

Quick Links

Home
About Us
Contact Us
Disclaimer
Privacy Policy

Home
About Us
Contact Us
Disclaimer
Privacy Policy

Categories

News
Featured
Stock Earnings
Insiders Updates
Analysts Viewpoint

News
Featured
Stock Earnings
Insiders Updates
Analysts Viewpoint

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in .

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

Enable or Disable Cookies Enabled Disabled

If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.